UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 14, 2017
Accession Number:
0001144204-17-020378
Submission Type:
POS AM
CIK:
0001563665
Company Name:
Biostage, Inc.
File Number:
333-215410